On November 2, 2020, (10:30 AM – 12:00 PM US ET) IPAC-RS is hosting a webinar with FDA: A Conversation with the FDA: Perspectives in the Time of COVID-19. Carla Vozone, Vice President, Pharmaceutical Development & Licensing at Hovione is a panelist in this discussion.
The IPAC-RS Regulatory Roundtable Series is focused on bringing together leaders in the Orally Inhaled and Nasal Drug Product (OINDP) space. Invited guests will include regulators, industry thought leaders, business leaders, academics, patient groups and others who comprise the OINDP “ecosystem.”
PANELISTS
Richard Lostritto, Associate Director for Science in Office of Policy for Pharmaceutical Quality (OPPQ)/OPQ/CDER/US Food and Drug Administration
Brian J. Hasselbalch, Deputy Director, OPPQ/OPQ/CDER/US Food and Drug Administration
Carla Vozone, Vice President, Pharmaceutical Development & Licensing, Hovione
Martin J. Oliver, Senior Vice President, Generic Programmes, Vectura Ltd.
MODERATOR
Mary Devlin Capizzi, IPAC-RS Secretariat and Legal Counsel; Partner, Faegre Drinker Biddle & Reath LLC
Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives